复星医药新董事长“接棒”!公司一季度成绩单“出炉”

国际金融报
Apr 30, 2025

4月29日盘后,复星医药发布2025年第一季度报告和新的董事会分工情况。今年第一季度复星医药营收94.2亿元,同比下滑7.26%;归母净利润7.65亿元,同比增长25.42%。管理层方面,吴以芳不再担任复星医药执行董事、董事长职务,改任复星医药非执行董事;王可心不再担任复星医药联席董事长,继续担任复星医药执行董事。陈玉卿接任复星医药董事长、执行董事;关晓晖不再担任副董事长,改任复星医药联席董事长、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10